I would say POSCO and Ganfeng make sense as front runners who have the most synergies to gain from the buy-in. I wouldn't rule Livent out though as that would diversify their portfolio and give them Stage 3 access.
This is a smart move. It sorts all funding issues, Stage 2 delayed which helps not oversupply market, helps funding and it helps us develop more data for running stage 1 properly which directly benefits stage 2 and 3.
It's a good announcement overall. US$375m for 25% would do me right now.
Ann: Stage 3 Partnering Process Commences, page-7
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.000(0.00%) |
Mkt cap ! $8.672B | |||
| Open | High | Low | Value | Volume |
| $2.37 | $2.43 | $2.33 | $89.10M | 37.39M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 146674 | $2.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.40 | 490312 | 15 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| PLS (ASX) Chart |
